September 15-18, 2025
Hynes Convention CenterBoston, USA Michael Chen, PhDCEO & Co-founder at Great Bay BioSpeaker
Profile
• Ph.D. in Biochemistry, University of Georgia, USA
• Led 5 IND filings for biosimilars and innovative macromolecules within 3 years
• Published 14 SCI papers and holds more than 20 patents
• More than 30 years’ experience in biopharmaceutical development and management
• Experienced in applying AI technology to biotechnology R&D
Agenda Sessions
Advantages of AI + Site-specific Integration Cell Line Development (AlfaCell) in CMC Bioprocessing, Bi-specific Antibody and ADC Development
, 3:15pmView Session